A decade-long follow-up study of more than 6,000 people who underwent heart computed tomography (CT) scans revealed that those with elevated coronary artery calcium scores might be at greater risk not only for heart and vascular disease, but also for cancer, chronic kidney disease, even chronic obstructive pulmonary disease (COPD). The study, “…
A new study investigated the differences in the services provided to patients with chronic obstructive pulmonary disease (COPD) by doctors and by nurse practitioners and physician assistants. The study was conducted by researchers from The University of Texas Medical Branch (UTMB) at Galveston, and published in the scientific periodical PLOS…
Propeller Health has partnered with Aptar Pharma, a drug delivery systems provider, for the development of technology based on metered dose inhaler systems (MDIs) for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Under the terms of the partnership, Propeller and Aptar will work to develop the…
A study recently published in the journal Chest found that patients with chronic obstructive pulmonary disease (COPD) had decreased gray matter in cerebral areas that process breathlessness, fear, and pain sensitivity. Intrapulmonary inflammatory processes restrict the flow of air in the lungs of people with COPD, and breathlessness is commonly experienced…
A new study led by researchers at Lund University, Sweden, showed that women may be at a considerably higher risk than men of developing chronic obstructive pulmonary disease (COPD). The study, “Incidence of airflow limitation in subjects 65-100 years of age,” was published in The European…
ResMed, a San Diego-based company that develops solutions for sleep-disordered breathing and respiratory care, recently announced it will acquire Inova Labs, a medical device company in Austin, Texas, that develops and commercializes advanced oxygen therapies. Oxygen therapy is the administration of oxygen as a medical intervention, and it can be used…
The Aerobika device, from Trudell Medical International in Canada, is a drug-free, easy-to-use, and clinically supported product to help patients with chronic obstructive pulmonary disease (COPD) and chronic bronchitis cope with the disease symptoms — especially in the colder winter months. The device opens up the lungs and creates…
Qualcomm Incorporated recently announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global partnership to advance a next generation inhaler to treat chronic obstructive pulmonary disease (COPD). Under the terms of the collaboration, Qualcomm Life is developing the reference design for the small and disposable module to power the next generation Breezhaler™, part of Novartis’…
GCE Healthcare recently announced the launch of the Zen-O portable oxygen concentrator (POC), a device designed to help patients with respiratory conditions, including chronic obstructive pulmonary disease (COPD), to better manage their oxygen therapy inside or outside the home. The device is the first product to be developed at GCE’s new manufacturing…
Scientists have created a model of the human small airway using organ-on-a-chip technology that can help researchers study inflammatory lung diseases like chronic obstructive pulmonary disease (COPD) and asthma outside a patient’s body, and potentially makes it possible to more easily identify new biomarkers and evaluate drug candidates. The study, by researchers at the Harvard John A.
Get regular updates to your inbox.